World's Best Scientists 2026 revealed!
Josep M. Llovet

Josep M. Llovet

Award Badge
Medicine
Spain
2025

D-Index & Metrics

Medicine

D-Index
143
Citations
147583
World Ranking
1461
National Ranking
15

Josep M. Llovet publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Josep M. Llovet sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Josep M. Llovet D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Josep M. Llovet sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 143 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Medicine in Spain Leader Award

Overview

Josep M. Llovet is affiliated with the University of Barcelona in Spain and is primarily engaged in research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work is focused on subfields such as Hepatology, Oncology, Cancer Research, Epidemiology, and Molecular Biology.

The scientist's research topics include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Ferroptosis and cancer prognosis
  • Cancer Genomics and Diagnostics
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Major venues where Josep M. Llovet has published include:

  • Journal of Hepatology
  • Journal of Clinical Oncology
  • JHEP Reports
  • Clinical Cancer Research
  • Annals of Oncology

Among recent papers authored or co-authored by Josep M. Llovet are:

  • Hepatocellular carcinoma, 2021, Nature Reviews Disease Primers
  • Immunotherapies for hepatocellular carcinoma, 2021, Nature Reviews Clinical Oncology
  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma, 2021, Nature Reviews Gastroenterology & Hepatology

Other prominent papers relevant to this scientist's field but with different primary authorship include:

  • AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma, 2023, Hepatology
  • Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma, 2020, Journal of Clinical Oncology

Frequent co-authors of Josep M. Llovet include:

  • Richard S. Finn
  • Roser Pinyol
  • Masatoshi Kudo
  • Augusto Villanueva
  • Daniela Sia

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma

    Peter R. Galle;Alejandro Forner;Josep M. Llovet;Vincenzo Mazzaferro

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • PROGNOSIS OF HEPATOCELLULAR CARCINOMA : THE BCLC STAGING CLASSIFICATION

    Josep M. Llovet;Concepció Brú;Jordi Bruix

  • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

    Josep M Llovet;Maria Isabel Real;Xavier Montaña;Ramon Planas

  • Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

    Josep M. Llovet;Jordi Bruix

  • Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

    Jordi Bruix;Shukui Qin;Philippe Merle;Alessandro Granito

  • EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

    Josep M. Llovet;Michel Ducreux;Riccardo Lencioni;Adrian M. Di Bisceglie

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Hepatocellular carcinoma.

    Josep M Llovet;Robin Kate Kelley;Augusto Villanueva;Amit G Singal

  • Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

    Josep M. Llovet;Josep Fuster;Jordi Bruix

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

    Kornelius Schulze;Sandrine Imbeaud;Eric Letouzé;Ludmil B. Alexandrov;Ludmil B. Alexandrov

  • Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

    Scott M. Wilhelm;Lila Adnane;Philippa Newell;Augusto Villanueva

  • Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Andrew X Zhu;Yoon-Koo Kang;Chia-Jui Yen;Richard S Finn

  • Molecular therapies and precision medicine for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Robert Montal;Daniela Sia;Richard S. Finn

  • Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

    John Bridgewater;Peter R. Galle;Shahid A. Khan;Josep M. Llovet

  • Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

    Xavier Forns;Sergi Ampurdanès;Josep M. Llovet;John Aponte

  • Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

    Josep M. Llovet;Javier Bustamante;Antoni Castells;Ramon Vilana

  • Prognostic prediction and treatment strategy in hepatocellular carcinoma

    Jordi Bruix;Josep M. Llovet

Frequent Co-Authors

Jordi Bruix
Jordi Bruix University of Barcelona
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Myron Schwartz
Myron Schwartz Icahn School of Medicine at Mount Sinai
Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Masatoshi Kudo
Masatoshi Kudo Kindai University
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Richard S. Finn
Richard S. Finn University of California, Los Angeles
Andrew X. Zhu
Andrew X. Zhu Harvard University
Peter R. Galle
Peter R. Galle Johannes Gutenberg University of Mainz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to varied healthcare careers, many of which can be accessed through online programs. For those aiming for advanced clinical practice, finding the cheapest dnp program can be a cost-effective path to becoming a nurse practitioner or clinical leader.

Pharmacists play a vital role in healthcare, and earning an online pharmd is an increasingly accessible route for those who wish to combine flexibility with rigorous training.

High school students considering a medical path can get a head start through the best online schools for high school students that offer health information management programs, giving early insight into healthcare systems.

Meanwhile, those interested in administrative roles should consider how affordable a program can be by asking how much is medical billing and coding school. These programs prepare students for in-demand jobs in medical billing and coding, often with flexible, online study options.

Best Scientists Citing Josep M. Llovet

Trending Scientists

Recently Published Articles